This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (25)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

Neal A. Halsey, MD

JAMA. 1999;282:1763-1766.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In late June of this year, the Food and Drug Administration (FDA) revealed that some infants who receive multiple doses of vaccines containing thimerosal could be exposed to total amounts of mercury that exceed some federal guidelines.¹ Thimerosal is a mercury-containing preservative used in some Haemophilus influenzae type b (Hib), diphtheria and tetanus toxoids with acellular pertussis (DTaP), hepatitis B, influenza, and other vaccines.² Federal agencies, the American Academy of Pediatrics (AAP), international agencies, and vaccine manufacturers have responded quickly to address the concern.^{1, 3, 5} However, more can be done to maintain public confidence in vaccines and to reduce childhood exposures to mercury from all sources.

Some confusion has occurred because of uncertainty regarding the applicability of guidelines for long-term exposures to methylmercury from environmental sources to intermittent exposures to ethylmercury, a breakdown product from thimerosal. Based on the limited data available, experts have concluded that the . . . [Full Text of this Article]

Author Affiliation: Institute for Vaccine Safety, Johns Hopkins School of Hygiene and Public Health, Baltimore, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Preventing Harm From Thimerosal in Vaccines
Paul A. Offit, Stanley A. Plotkin, and Neal A. Halsey
JAMA. 2000;283(16):2104-2105.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Hepatitis B Vaccination Among Children in Inner-City Public Housing, 1991-1997
Diane S. Lauderdale, Ronda J. Oram, Karen P. Goldstein, and Robert S. Daum
JAMA. 1999;282(18):1725-1730.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mercury, Vaccines, and Autism: One Controversy, Three Histories
Baker
Am. J. Public Health 2008;98:244-253.
ABSTRACT | FULL TEXT  

The Immunologic Basis for Neonatal Immunizations
Baley and Leonard
NeoReviews 2005;6:e463-e470.
FULL TEXT  

Enhancing Public Confidence in Vaccines Through Independent Oversight of Postlicensure Vaccine Safety
Salmon et al.
Am. J. Public Health 2004;94:947-950.
ABSTRACT | FULL TEXT  

Rotavirus Vaccine and the News Media, 1987-2001
Danovaro-Holliday et al.
JAMA 2002;287:1455-1462.
ABSTRACT | FULL TEXT  

Hepatitis B Vaccination Practices in Hospital Newborn Nurseries Before and After Changes in Vaccination Recommendations
Clark et al.
Arch Pediatr Adolesc Med 2001;155:915-920.
ABSTRACT | FULL TEXT  

Balancing Risks and Benefits: Primum non nocere Is Too Simplistic
Halsey and Goldman
Pediatrics 2001;108:466-467.
FULL TEXT  

Preventing Harm From Thimerosal in Vaccines
Offit et al.
JAMA 2000;283:2104-2105.
FULL TEXT